Women and CKD-mineral and bone disorder

Advances in Chronic Kidney Disease

Volumn 20, Issue 5, 2013, Pages 423-426

  Ho, L Tammy ^a   Sprague, Stuart M ^a  

^a NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

Author keywords

CKD mineral bone disorder; Fibroblast growth factor 23; Kidney osteodystrophy; Phosphorus

Indexed keywords

ALKALINE PHOSPHATASE BONE ISOENZYME; CALCIUM; FIBROBLAST GROWTH FACTOR 23; PARATHYROID HORMONE; PHOSPHORUS; VITAMIN D;

ALBRIGHT SYNDROME; BLOOD VESSEL CALCIFICATION; BONE DENSITOMETRY; BONE DENSITY; BONE MASS; BONE TURNOVER; CALCIFICATION; CALCIUM BALANCE; CALCIUM BLOOD LEVEL; CALCIUM INTAKE; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CHRONIC KIDNEY DISEASE MINERAL AND BONE DISORDER; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY CALCIFICATION; DIET SUPPLEMENTATION; ESTROGEN THERAPY; FRACTURE; HEMODIALYSIS; HUMAN; INCIDENCE; MINERAL BALANCE; MORBIDITY; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOLYSIS; OSTEOPOROSIS; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; POPULATION; POSTMENOPAUSE; PRIORITY JOURNAL; RENAL OSTEODYSTROPHY; REVIEW; SEX DIFFERENCE; URINARY EXCRETION; VITAMIN BLOOD LEVEL;

CKD-MINERAL BONE DISORDER; FIBROBLAST GROWTH FACTOR-23; KIDNEY OSTEODYSTROPHY; PHOSPHORUS;

BONE DENSITY; BONE DISEASES, METABOLIC; CALCINOSIS; CALCIUM; CARDIOVASCULAR DISEASES; FEMALE; FIBROBLAST GROWTH FACTORS; HUMANS; MALE; PHOSPHORUS; RENAL INSUFFICIENCY, CHRONIC; RENAL OSTEODYSTROPHY; SEX FACTORS;

EID: 84882803446     PISSN: 15485595     EISSN: 15485609     Source Type: Journal    
DOI: 10.1053/j.ackd.2013.06.007     Document Type: Review

References (27)

1. Goodman W., Goldin J., Kuizon B. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 2000, 342(20):1478-1483.
2. Coco M., Rush H. Increased incidence of hip fracture in dialysis patients with low serum parathyroid hormone. Am J Kidney Dis 2000, 36(6):1115-1121.
3. U.S. Renal Data System, USRDS 2012 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2012.
4. Chertow G.M., Raggi P., Chasan-Taber S., Bommer J., Holzer H., Burke S.K. Determinants of progressive vascular calcification in hemodialysis patients. Nephrol Dial Transplant 2004, 19(6):1489-1496.
5. Dellagrottaglie S., Rajiv S., Gillespie B., et al. Prevalence and predictors of cardiovascular calcification in chronic kidney disease. Am J Cardiol 2006, 98(6):571-576.
6. Urena P., Hruby M., Ferreira A., et al. Plasma total versus bone alkaline phosphatase as markers of bone turnover in hemodialysis patients. J Am Soc Nephrol 1996, 7(3):506-512.
7. Reid I., Ames R., Evans M., Gamble G., Sharpe S. Effect of calcium supplementation on bone loss in postmenopausal women. N Engl J Med 1993, 328(7):460-464.
8. Hill K., Martin B., Wastney M. Oral calcium supplementation affects calcium but not phosphorus balance in stage 3-4 chronic kidney disease. Kidney Int 1993, 83(5):959-966.
9. Dhingra R., Sullivan L.M., Fox C.S., et al. Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community. Arch Intern Med 2007, 167(9):879-885.
10. Tonelli M., Sacks F., Pfeffer M., Gao Z., Curhan G. Relation between serum phosphorus and cardiovascular event rate in people with coronary disease. Circulation 2007, 112(17):2627-2633.
11. O'Seaghdha C., Hwang S., Muntner P., Melamed M., Fox C. Serum phosphorus predicts incident chronic kidney disease and end stage renal disease. Nephrol Dial Transplant 2011, 26(9):2885-2890.
12. Klawansky S., Komaroff E., Cavanaugh P., et al. Relationship between age, renal function and bone mineral density in the US population. Osteoporos Int 2003, 14(7):570-576.
13. Onufrak S., Bellasi A., Carderelli F., et al. Investigation of gender heterogeneity in the associations of serum phosphorus with incident coronary artery disease and all-cause mortality. Am J Epidemiol 2008, 169(1):67-77.
14. Saab G., Whooley M.A., Schiller N.B., et al. Association of serum phosphorus with left ventricular mass in men and women with stable cardiovascular disease: data from the Heart and Soul study. Am J Kidney Dis 2010, 56(3):496-505.
15. Liu S., Quarles L.D. How fibroblast growth factor 23 works. J Am Soc Nephrol 2007, 18(6):1637-1647.
16. Gutierrez O.M., Mannstadt M., Isakova T., et al. Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. New Engl J Med 2008, 359(6):584-592.
17. Ix J., Chonchoi M., Laughlin G., Shlipak M., Whooley M. Relation of sex and estrogen therapy to serum fibroblast growth factor 23, serum phosphorus and urine phosphorus: the Heart and Soul study. Am J Kidney Dis 2011, 58(5):737-745.
18. Olauson H., Qureshi A., Miyamoto T., et al. Relationship between serum fibroblast growth factor-23 level and mortality in incident patients: are gender and cardiovascular disease confounding the relationship?. Nephrol Dial Transplant 2010, 25(9):3033-3038.
19. Faroqui s, Levi M., Soleimani M., Amlal H. Estrogen downregulates the proximal tubule type IIa sodium phosphate cotransporter causing phosphate wasting and hypophosphatemia. Kidney Int 2008, 73(10):1141-1150.
20. Alem A.M., Sherrard D.J., Gillen D.L., et al. Increased risk of hip fracture among patients with end stage renal disease. Kidney Int 2000, 58(1):396-399.
21. Cunningham J., Sprague S.M., Cannata-Andia J., et al. Osteoporosis in chronic kidney disease. Am J Kidney Dis 2004, 43(3):566-571.
22. Barreto F., Barreto D., Moyses R. Osteoporosis in hemodialysis patients revisited by bone histomorphometry: a new insight into an old problem. Kidney Int 2006, 69(10):1852-1857.
23. Ott S.M. Bone histomorphometry in renal osteodystrophy. Semin Nephrol 2009, 29:122-132.
24. Jamal S.A., Gilbert J., Gordon C., Bauer D.C. Cortical pQCT measures are associated with fractures in dialysis patients. J Bone Miner Res 2006, 21(4):543-548.
25. Cauley J.A., Lacroix A.Z., Wu L., Horwitz M. Serum 25-hydroxyvitamin D concentrations and risk for hip fractures. Ann Intern Med 2008, 149(4):242-250.
26. Jackson R.D., LaCroix A.Z., Gass M. Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med 2006, 354(7):669-683.
27. Minisola S., Dionisi S., Pacitti M. Gender differences in serum markers of bone resorption in healthy subjects and patients with disorders affecting bone. Osteoporos Int 2002, 13(2):171-175.